Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
Inflammation in CKD and CVD - The Role of Genetics and IL-1ra
Sponsor: VA Office of Research and Development
A PHASE2 clinical study on Cardiovascular Disease and Chronic Kidney Disease, this trial is completed. The trial is conducted by VA Office of Research and Development and has accumulated 11 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Mar 2019 — Nov 2019 [monthly]
Completed PHASE2
▶ Show 6 earlier versions
-
Dec 2018 — Mar 2019 [monthly]
Completed PHASE2
-
Aug 2018 — Dec 2018 [monthly]
Completed PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE2
Phase: NA → PHASE2
-
May 2017 — Feb 2018 [monthly]
Completed NA
-
Jan 2017 — May 2017 [monthly]
Completed NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .